This inventor holds 2 USPTO granted patents. Top assignee: Smithkline Beecham Corporation. Active years: 2003-2005.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2003-2005
Title: The Innovative Journey of Michelle Joanne Fugett
Introduction
Michelle Joanne Fugett is a distinguished inventor based in Durham, North Carolina, with a strong emphasis on pharmaceutical innovations. She has made notable contributions to the field, holding a total of two patents that reflect her expertise and innovative spirit.
Latest Patents
One of her latest patents focuses on Chloropyrimidine intermediates. This invention relates to certain novel pyrimidine intermediates and their salts, alongside the processes for their preparation. Additionally, it details the processes for their conversion to 9-substituted-2-aminopurines, which are recognized for their potential use in medical therapy. This innovative work showcases her commitment to advancing medical science through her inventions.
Career Highlights
Michelle is an integral part of the Smithkline Beecham Corporation, where her research plays a pivotal role in the development of novel medicinal compounds. Her tenure at this firm has positioned her as a key player in the pharmaceutical industry, driving forward innovations that can significantly impact health outcomes.
Collaborations
Throughout her career, Michelle has collaborated with prominent colleagues, including Susan Mary Daluge and Michael Tolar Martin. These partnerships have fostered a collaborative environment that thrives on shared knowledge and expertise, further enhancing the innovative projects they undertake together.
Conclusion
Michelle Joanne Fugett exemplifies the spirit of innovation through her dedicated work as an inventor. Her contributions to pharmaceutical science, particularly in the development of Chloropyrimidine intermediates, highlight her significant role in advancing medical therapies. As she continues her work at Smithkline Beecham Corporation, her future inventions are anticipated to offer further breakthroughs in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile